A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults (NCT07363148)
A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to investigate the safety and efficacy of MB-1 on metabolic health in overweight and obese adults. The main question it aims to answer is: What is the difference in change in body weight from baseline at Day 84 between MB-1 and placebo? Participants will be provided MB-1 or placebo and be assessed for anthropometric measurements, blood pressure, heart rate, and asked to complete appetite and satiety questionnaires and undergo a DEXA scan.
Who can join: Review the eligibility criteria below.
Location: KGK Science Inc. — London, Ontario
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- KGK Science Inc. — London, Ontario
📞 Contact the Study Coordinator
Phone: (226) 781-9094
Email: mmoulin@kgkscience.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obese
- Aleniglipron Phase 2 in Type 2 Diabetes Mellitus — Anniston, Alabama
- Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus — Chula Vista, California
- A Study of Distal Jejunal-release Dextrose in Obese Participants — Tbilisi,
- Brain Fuel - Morning Nutrition and Cognitive Function — Little Rock, Arkansas
- Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors — Montreal, Quebec
Explore by condition: All Obese clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.